Oligomeric Protein LPS Binding via Coiled-Coil Structure

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for removing and detecting lipopolysaccharides (LPS) face challenges such as low binding affinity, non-specific interactions, and aggregation issues, leading to inefficiencies and inconsistencies in endotoxin removal and detection, particularly in pharmaceutical and medical applications.

Innovation Solution

Development of an oligomeric protein with an alpha-helical coiled-coil structure, based on the GCN4 protein, which binds to LPS with high affinity through its lipid A component, capable of forming dimers, trimers, or tetramers, and can be immobilized for use in columns or filters for removal and detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If polymyxin B is used as an endotoxin-binding molecule, then binding specificity is improved, but binding affinity is insufficient (micromolar range only)

Engineering Contradiction:
Improvebinding specificityVSAvoidbinding affinity
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent changes the binding affinity parameter by using an oligomeric protein with a coiled-coil structure that provides nanomolar binding affinity, significantly improving upon the micromolar range of polymyxin B while maintaining specificity through the structured interaction with lipid A

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If poly-lysine polymers are used to bind endotoxins, then binding capability is improved, but non-specific interactions increase

Engineering Contradiction:
Improvebinding capabilityVSAvoidspecificity
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies local quality by creating a specific binding interface through the coiled-coil structure that interacts selectively with the lipid A component of LPS, rather than using non-specific electrostatic interactions like poly-lysine. The structured helical arrangement provides localized specific binding sites that avoid non-specific interactions with other negatively charged molecules

Inventive Principle:
Principle #3Local quality

3Productivity

If ion exchange chromatography is used for endotoxin removal, then removal efficiency is improved, but competition from other charged particles reduces efficiency

Engineering Contradiction:
Improveremoval efficiencyVSAvoidselectivity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent uses an intermediary approach by employing the oligomeric protein as a selective mediator that binds LPS through specific structural interactions with lipid A, rather than relying on non-specific electrostatic interactions. This intermediary protein provides selective binding that is not competed by other charged particles in the sample

Inventive Principle:
Principle #24Intermediary (Mediator)

4Measurement precision

If traditional LAL assay is used for endotoxin detection, then detection capability is improved, but cost and sustainability deteriorate

Engineering Contradiction:
Improvedetection capabilityVSAvoidcost and sustainability
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent applies copying by creating a simplified, sustainable alternative to the complex LAL assay system. Instead of using expensive horseshoe crab amebocyte lysate, the patent uses a recombinant oligomeric protein that can be produced in bacterial expression systems, providing the same detection capability at lower cost and with better sustainability

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The oligomeric protein effectively binds and removes LPS with high specificity, even at low concentrations, reducing aggregation-related masking effects and providing a cost-effective, sustainable alternative to traditional methods like the Limulus amebocyte lysate assay, enhancing the reliability of endotoxin detection and removal processes.

Implementation Method 1

an oligomeric protein having a coiled coil structure as a binding agent for binding to lipopolysaccharide (LPS)

Methodology Applied
Scientific EffectNon-covalent binding:

Implementation Method 2

The coiled coil structure comprises at least 2 monomer peptides... each monomer peptide is capable of forming an α-helix... comprising at least one core sequence having at least 60% sequence identity to the heptad repeat sequence

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS20230243817A1Uses, methods and products relating to oligomeric lipopolysaccharide binding proteins
Publication Date: 2023.08.03 UNIVERSITY OF OSLO
  • US20230243817A1 patent drawing
  • US20230243817A1 patent drawing
  • US20230243817A1 patent drawing

AI summary

Provided and described herein is the use of an oligomeric protein as a binding agent for binding to lipopolysaccharide (LPS), the oligomeric protein having a coiled coil structure comprising at least two monomer peptides, wherein each monomer peptide, which may be the same or different, is capable of forming an α-helix and comprises at least one core sequence having at least 60% sequence identity to the heptad repeat sequence of SEQ ID NO. 1. Also provide and described herein are methods of binding, detecting and removing LPS, and products comprising the oligomeric protein.